{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:37:13Z","timestamp":1761917833934},"reference-count":29,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T00:00:00Z","timestamp":1475625600000},"content-version":"vor","delay-in-days":278,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/j.medici.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T03:13:17Z","timestamp":1476673997000},"page":"315-320","source":"Crossref","is-referenced-by-count":4,"title":["Use of drugs against osteoporosis in the Baltic countries during 2010\u20132014"],"prefix":"10.3390","volume":"52","author":[{"given":"Ott","family":"Laius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katre","family":"Maasalu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulev","family":"K\u00f5ks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aare","family":"M\u00e4rtson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","reference":[{"key":"10.1016\/j.medici.2016.10.001_bib0150","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/oxfordjournals.epirev.a036281","article-title":"Epidemiology of osteoporosis and osteoporotic fractures","author":"Cummings","year":"1985","journal-title":"Epidemiol Rev"},{"issue":"3","key":"10.1016\/j.medici.2016.10.001_bib0155","first-page":"465","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone"},{"issue":"1","key":"10.1016\/j.medici.2016.10.001_bib0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bone.2008.09.006","article-title":"Effectiveness of bisphosphonate therapy in a community setting","volume":"44","author":"Feldstein","year":"2009","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.medici.2016.10.001_bib0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/17453670710015094","article-title":"Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden","volume":"79","author":"Str\u00f6m","year":"2008","journal-title":"Acta Orthop"},{"issue":"11","key":"10.1016\/j.medici.2016.10.001_bib0170","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00198-004-1627-0","article-title":"An estimate of the worldwide prevalence, mortality and disability associated with hip fracture","volume":"15","author":"Johnell","year":"2004","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"10","key":"10.1016\/j.medici.2016.10.001_bib0175","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s001980200107","article-title":"Committee of Scientific Advisors International Osteoporosis Foundation. A systematic review of health state utility values for osteoporosis-related conditions","volume":"13","author":"Brazier","year":"2002","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"3","key":"10.1016\/j.medici.2016.10.001_bib0180","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-012-2240-2","article-title":"The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS) \u2013 quality of life during the first 4 months after fracture","volume":"24","author":"Borgstr\u00f6m","year":"2013","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"1","key":"10.1016\/j.medici.2016.10.001_bib0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00198-010-1274-6","article-title":"Oral bisphosphonate compliance and persistence: a matter of choice?","volume":"22","author":"Silverman","year":"2011","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"9319","key":"10.1016\/j.medici.2016.10.001_bib0190","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.medici.2016.10.001_bib0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"issue":"9322","key":"10.1016\/j.medici.2016.10.001_bib0200","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","article-title":"Treatment of postmenopausal osteoporosis","volume":"359","author":"Delmas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.medici.2016.10.001_bib0205","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00198-010-1223-4","article-title":"Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club","volume":"21","author":"Body","year":"2010","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"3","key":"10.1016\/j.medici.2016.10.001_bib0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","article-title":"Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis","volume":"148","author":"MacLean","year":"2008","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.medici.2016.10.001_bib0215","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","article-title":"Compliance with drug therapies for the treatment and prevention of osteoporosis","volume":"48","author":"McCombs","year":"2004","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.medici.2016.10.001_bib0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/qjmed\/hcn130","article-title":"The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates","volume":"102","author":"Rietbrock","year":"2009","journal-title":"QJM"},{"issue":"10","key":"10.1016\/j.medici.2016.10.001_bib0225","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-004-1675-5","article-title":"Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review","volume":"15","author":"Elliot-Gibson","year":"2004","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.medici.2016.10.001_bib0230","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jc.2003-030501","article-title":"The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial","volume":"89","author":"Clowes","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.medici.2016.10.001_bib0235","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","article-title":"A systematic review of persistence and compliance with bisphosphonates for osteoporosis","volume":"18","author":"Cramer","year":"2007","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"1\u20132","key":"10.1016\/j.medici.2016.10.001_bib0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11657-013-0137-0","article-title":"Osteoporosis in the European Union: a compendium of country-specific reports","volume":"8","author":"Svedbom","year":"2013","journal-title":"Arch Osteoporos"},{"issue":"1\u20132","key":"10.1016\/j.medici.2016.10.001_bib0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-011-0060-1","article-title":"Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"6","author":"Str\u00f6m","year":"2011","journal-title":"Arch Osteoporos"},{"issue":"1","key":"10.1016\/j.medici.2016.10.001_bib0250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.maturitas.2012.10.002","article-title":"Trends in the pharmacological treatment of osteoporosis in Spain from 2000 to 2008","volume":"74","author":"Salgueiro","year":"2013","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.medici.2016.10.001_bib0255","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bone.2013.09.008","article-title":"Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002\u20132012","volume":"57","author":"Wysowski","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.medici.2016.10.001_bib0260","series-title":"Baltic statistics on medicines 2010\u20132012","author":"Rootslane","year":"2013"},{"key":"10.1016\/j.medici.2016.10.001_bib0265","series-title":"Estonian State Agency of Medicines website","year":"2015"},{"key":"10.1016\/j.medici.2016.10.001_bib0270","series-title":"Latvian State Agency of Medicines website","year":"2015"},{"key":"10.1016\/j.medici.2016.10.001_bib0275","series-title":"Lithuanian Medicines Control Agency website","year":"2015"},{"issue":"5","key":"10.1016\/j.medici.2016.10.001_bib0280","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.21607","article-title":"Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000\u20132007): hip fracture incidence and change in antiosteoporosis medications","volume":"64","author":"Hiligsmann","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.medici.2016.10.001_bib0285","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1377\/hlthaff.21.2.245","article-title":"The effects of obesity, smoking, and drinking on medical problems and costs","volume":"21","author":"Sturm","year":"2002","journal-title":"Health Aff Proj Hope"},{"key":"10.1016\/j.medici.2016.10.001_bib0290","series-title":"Adherence to long-term therapies: evidence for action","author":"Sabat\u00e9","year":"2003"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1010660X16300611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1010660X16300611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T20:07:09Z","timestamp":1525723629000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010660X16300611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"alternative-id":["S1010660X16300611"],"URL":"https:\/\/doi.org\/10.1016\/j.medici.2016.10.001","relation":{},"ISSN":["1010-660X"],"issn-type":[{"value":"1010-660X","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}